Albemarle (ALB) Cost of Revenue (2009 - 2026)

Albemarle (ALB) has 18 years of Cost of Revenue data on file, last reported at $927.8 million in Q1 2026.

• Quarterly Cost of Revenue rose 0.78% year-over-year to $927.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.5 billion (down 8.8% YoY) and the FY2025 annual result came in at $4.5 billion, down 15.82% from the prior year.
• Cost of Revenue fell to $927.8 million in Q1 2026, from $1.2 billion in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $3.1 billion in Q4 2023 to a low of $678.7 million in Q1 2022.
• A 5-year average of $1.4 billion and a median of $1.2 billion in 2025 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2022 — Cost of Revenue surged 146.29% — and 2024, when it slumped 64.27%.
• Tracing ALB's Cost of Revenue over 5 years: stood at $1.6 billion in 2022, then surged by 88.94% to $3.1 billion in 2023, then tumbled by 64.27% to $1.1 billion in 2024, then advanced by 12.49% to $1.2 billion in 2025, then declined by 24.58% to $927.8 million in 2026.
• The last three Cost of Revenue figures came in at $927.8 million (Q1 2026), $1.2 billion (Q4 2025), and $1.2 billion (Q3 2025), per Business Quant data.